Anti‐inflammatory effect of lanoconazole on 12‐O‐tetradecanoylphorbol‐13‐acetate‐ and 2, 4, 6‐trinitrophenyl chloride–induced skin inflammation in mice. Issue 2 (27th November 2019)
- Record Type:
- Journal Article
- Title:
- Anti‐inflammatory effect of lanoconazole on 12‐O‐tetradecanoylphorbol‐13‐acetate‐ and 2, 4, 6‐trinitrophenyl chloride–induced skin inflammation in mice. Issue 2 (27th November 2019)
- Main Title:
- Anti‐inflammatory effect of lanoconazole on 12‐O‐tetradecanoylphorbol‐13‐acetate‐ and 2, 4, 6‐trinitrophenyl chloride–induced skin inflammation in mice
- Authors:
- Nakamura, Aki
Uratsuji, Hideya
Yamada, Yoshihito
Hashimoto, Kei
Nozawa, Naoki
Matsumoto, Tatsumi - Abstract:
- Summary: Background: Lanoconazole (LCZ) is a topical antifungal agent clinically used to treat fungal infections such as tinea pedis. LCZ has not only antifungal effects but also anti‐inflammatory effects, which have the potential to provide additional clinical benefits. However, the characteristic features of the inhibitory effects of LCZ on skin inflammation remain unclear. Objective: We evaluated the inhibitory effects of topical application of LCZ, and compared the effects of LCZ with those of other antifungal agents including liranaftate, terbinafine and amorolfine. Methods: Each antifungal agent was topically applied on 12‐ O ‐tetradecanoylphorbol‐13‐acetate‐induced irritant dermatitis and 2, 4, 6‐trinitrophenyl chloride‐induced contact dermatitis in mice (BALB/c). The ear thickness, myeloperoxidase activity and inflammatory mediator contents were evaluated. Results: LCZ dose‐dependently suppressed 12‐ O ‐tetradecanoylphorbol‐13‐acetate‐induced irritant dermatitis, suppressed the production of neutrophil chemotactic factors such as keratinocyte‐derived chemokine and macrophage inflammatory protein‐2, and inhibited neutrophil infiltration to the inflammation site. Moreover, 1% LCZ reduced the ear swelling in mice with 2, 4, 6‐trinitrophenyl chloride‐induced contact dermatitis in accordance with the inhibition of interferon‐γ production. The inhibitory potency of LCZ on these types of dermatitis in mice was stronger than that of other types of antifungal agents.Summary: Background: Lanoconazole (LCZ) is a topical antifungal agent clinically used to treat fungal infections such as tinea pedis. LCZ has not only antifungal effects but also anti‐inflammatory effects, which have the potential to provide additional clinical benefits. However, the characteristic features of the inhibitory effects of LCZ on skin inflammation remain unclear. Objective: We evaluated the inhibitory effects of topical application of LCZ, and compared the effects of LCZ with those of other antifungal agents including liranaftate, terbinafine and amorolfine. Methods: Each antifungal agent was topically applied on 12‐ O ‐tetradecanoylphorbol‐13‐acetate‐induced irritant dermatitis and 2, 4, 6‐trinitrophenyl chloride‐induced contact dermatitis in mice (BALB/c). The ear thickness, myeloperoxidase activity and inflammatory mediator contents were evaluated. Results: LCZ dose‐dependently suppressed 12‐ O ‐tetradecanoylphorbol‐13‐acetate‐induced irritant dermatitis, suppressed the production of neutrophil chemotactic factors such as keratinocyte‐derived chemokine and macrophage inflammatory protein‐2, and inhibited neutrophil infiltration to the inflammation site. Moreover, 1% LCZ reduced the ear swelling in mice with 2, 4, 6‐trinitrophenyl chloride‐induced contact dermatitis in accordance with the inhibition of interferon‐γ production. The inhibitory potency of LCZ on these types of dermatitis in mice was stronger than that of other types of antifungal agents. Conclusion: The anti‐inflammatory effects of LCZ were exerted through the inhibition of inflammatory mediator production. These effects may contribute to the relief of dermatitis symptoms in patients with tinea pedis. … (more)
- Is Part Of:
- Mycoses. Volume 63:Issue 2(2020)
- Journal:
- Mycoses
- Issue:
- Volume 63:Issue 2(2020)
- Issue Display:
- Volume 63, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 63
- Issue:
- 2
- Issue Sort Value:
- 2020-0063-0002-0000
- Page Start:
- 189
- Page End:
- 196
- Publication Date:
- 2019-11-27
- Subjects:
- antifungal agents -- anti‐inflammatory agents -- chemokines -- CXC -- dermatitis:contact -- dermatitis:irritant -- dermatomycoses -- lanoconazole -- pharmacology
Pathogenic fungi -- Periodicals
Medical mycology -- Periodicals
616.969 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1111/myc.13034 ↗
- Languages:
- English
- ISSNs:
- 0933-7407
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5995.753000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17129.xml